Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-13

Clinical Trial Update: GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients

View source ↗

Summary

Observation study completion update for GLucobay (miglitol) evaluating efficacy and safety in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucobay (acarbose)

Snippet

Sponsor: Bayer | Conditions: Type 2 Diabetes | Status: COMPLETED